-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Tg Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2024.
- Tg Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $29.9M.
- Tg Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $41.9M, a 103% increase year-over-year.
- Tg Therapeutics, Inc. annual Operating Income (Loss) for 2024 was $41.9M, a 103% increase from 2023.
- Tg Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $20.6M.
- Tg Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$218M, a 36.7% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)